WM President and CEO Jim Fish joins 'Mad Money' host Jim Cramer to talk quarterly results, teh industrial end market, its workforce and more.
Waste Management, Inc. has strong growth prospects driven by pricing power, Stericycle acquisition, and investments in recycling and renewable natural gas projects. Margins are expected to improve due to favorable price/cost dynamics, cost optimization, automation, and cost synergies from the Stericycle acquisition. The stock is trading at a discount compared to historical averages and peers, making it an attractive Buy given its growth potential.
Stericycle (SRCL) is benefiting from steady revenue flow and acquisitions amid rising competition.
NEW ORLEANS, LA / ACCESSWIRE / June 5, 2024 / Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Stericycle (SRCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Waste Management (WM) has reached an agreement to acquire medical waste disposal company Stericycle (SRCL) in a deal valued at $7.2 billion including debt, sending the latter's stock significantly higher Monday.
Waste Management will acquire Stericycle in a $7.2 billion deal, the companies said Monday. WM will acquire all outstanding shares of Stericycle for $62 per share in cash, representing the deal's total value when including Stericycle's net debt of around $1.4 billion.
Stericycle Inc. (NASDAQ:SRCL) is in the spotlight as Waste Management Inc. (NYSE: WM) moves closer to acquiring the medical waste disposal company for $7 billion, including debt. This potential deal, reported by The Wall Street Journal on June 2nd, could be announced soon.
Waste Management is nearing a deal to buy medical-waste-disposal company Stericycle for roughly $7 billion including debt.
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts.
SRCL's Q1 2024 operating margins beat expectations, and the company's EBITDA margin is expected to improve significantly for full-year 2024. I anticipate that Stericycle's Secure Information Destruction segment can realize a turnaround due to a more favorable base for YoY comparison in 2H and the introduction of a subscription service. My Buy rating for SRCL stays intact following an assessment of its outlook and valuations.